Targeted NNMT Inhibitor for Cellular Energy & Fat Metabolism 5-Amino-1MQ is a selective, small-molecule inhibitor of Nicotinamide N-methyltransferase (NNMT). Designed to optimize cellular NAD+ availability, enhance basal metabolic rate, and support lean muscle preservation without affecting central nervous system activity.

Advanced Nootropic Peptide for Cognitive Enhancement & Focus Adamax is an upgraded, high-potency derivative of Semax designed to elevate cognitive performance, sharpen focus, and support neuroplasticity. Engineered for enhanced bioavailability and prolonged activity, it represents the next generation of brain health and research peptides.

Targeted Metabolic & Cardiovascular Research (B7-33 Peptide) B7-33 is a novel, rationally designed single-chain relaxin receptor (RXFP1) agonist. Engineered as a non-fibrotic and non-mitogenic analog of relaxin-2, it provides targeted support for cardiovascular protection, tissue remodeling, and antifibrotic research.

Premium Cellular Repair & Tissue Regeneration Peptide BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide widely studied for its powerful cytoprotective and healing properties. Designed to accelerate tendon, muscle, ligament, and gut lining recovery, it represents a gold standard in advanced tissue regeneration research.

Advanced Dual-Mechanism Weight & Metabolic Management (Cagrilintide + Semaglutide) CagriSema combines the long-acting amylin analogue Cagrilintide with the GLP-1 receptor agonist Semaglutide. Designed to target dual metabolic pathways for deep satiety, enhanced appetite suppression, and superior body composition management.

Targeted Growth Hormone Release & Recovery Optimization CJC-1295 (without DAC), also known as Modified GRF (1-29), is a potent growth hormone-releasing hormone (GHRH) analog designed for precise, pulsatile stimulation of natural GH production. Perfect for targeted recovery, lean muscle support, and metabolic research.